Diffuse follicle center lymphoma, intrathoracic lymph nodes
ICD-10 C82.52 is a billable code used to indicate a diagnosis of diffuse follicle center lymphoma, intrathoracic lymph nodes.
Diffuse follicle center lymphoma (DFCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells within the follicle center of lymphoid tissue. This specific code, C82.52, indicates that the lymphoma is primarily located in the intrathoracic lymph nodes, which include mediastinal and hilar lymph nodes. Clinically, patients may present with symptoms such as lymphadenopathy, fatigue, and B-symptoms, which include fever, night sweats, and weight loss. The staging of DFCL is crucial for determining the prognosis and treatment approach, typically following the Ann Arbor staging system. Treatment options may include chemotherapy, immunotherapy, and radiation therapy, depending on the stage and individual patient factors. Accurate coding is essential for appropriate reimbursement and tracking of treatment outcomes.
Detailed clinical notes on patient history, physical examination findings, and treatment plans.
Diagnosis and management of patients with diffuse follicle center lymphoma, staging evaluations, and treatment response assessments.
Ensure thorough documentation of B-symptoms and staging to support coding.
Imaging reports that clearly indicate the location and size of lymph nodes.
Imaging studies for staging and monitoring treatment response in lymphoma patients.
Radiology reports should correlate findings with clinical symptoms and staging.
Used for patients receiving chemotherapy for diffuse follicle center lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy administration.
Common symptoms include lymphadenopathy, fatigue, fever, night sweats, and weight loss. These symptoms are often referred to as B-symptoms.
